234 related articles for article (PubMed ID: 19916554)
21. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
Lepesheva GI; Waterman MR
Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
[TBL] [Abstract][Full Text] [Related]
22. Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases.
Santucci M; Luciani R; Gianquinto E; Pozzi C; Pisa FD; Dello Iacono L; Landi G; Tagliazucchi L; Mangani S; Spyrakis F; Costi MP
Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959646
[TBL] [Abstract][Full Text] [Related]
23. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
[TBL] [Abstract][Full Text] [Related]
25. Dual and selective inhibitors of pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHFR-TS) from
Teixeira BVF; Teles ALB; Silva SGD; Brito CCB; Freitas HF; Pires ABL; Froes TQ; Castilho MS
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1439-1450. PubMed ID: 31409157
[TBL] [Abstract][Full Text] [Related]
26. Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate.
Dawson A; Gibellini F; Sienkiewicz N; Tulloch LB; Fyfe PK; McLuskey K; Fairlamb AH; Hunter WN
Mol Microbiol; 2006 Sep; 61(6):1457-68. PubMed ID: 16968221
[TBL] [Abstract][Full Text] [Related]
27. Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors.
Corona P; Gibellini F; Cavalli A; Saxena P; Carta A; Loriga M; Luciani R; Paglietti G; Guerrieri D; Nerini E; Gupta S; Hannaert V; Michels PA; Ferrari S; Costi PM
J Med Chem; 2012 Oct; 55(19):8318-29. PubMed ID: 22946585
[TBL] [Abstract][Full Text] [Related]
28. Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign.
Linciano P; Cullia G; Borsari C; Santucci M; Ferrari S; Witt G; Gul S; Kuzikov M; Ellinger B; Santarém N; Cordeiro da Silva A; Conti P; Bolognesi ML; Roberti M; Prati F; Bartoccini F; Retini M; Piersanti G; Cavalli A; Goldoni L; Bertozzi SM; Bertozzi F; Brambilla E; Rizzo V; Piomelli D; Pinto A; Bandiera T; Costi MP
Eur J Med Chem; 2020 Mar; 189():112047. PubMed ID: 31982652
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and Genetic Tests for Inhibitors of Leishmania Pteridine Pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):158-70. PubMed ID: 9398595
[TBL] [Abstract][Full Text] [Related]
31. In silico drug re-purposing against African sleeping sickness using GlcNAc-PI de-N-acetylase as an experimental target.
Rashmi M; Swati D
Comput Biol Chem; 2015 Dec; 59 Pt A():87-94. PubMed ID: 26476127
[TBL] [Abstract][Full Text] [Related]
32. Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1.
Khalaf AI; Huggan JK; Suckling CJ; Gibson CL; Stewart K; Giordani F; Barrett MP; Wong PE; Barrack KL; Hunter WN
J Med Chem; 2014 Aug; 57(15):6479-94. PubMed ID: 25007262
[TBL] [Abstract][Full Text] [Related]
33. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors.
Leite FHA; Froes TQ; da Silva SG; de Souza EIM; Vital-Fujii DG; Trossini GHG; Pita SSDR; Castilho MS
Eur J Med Chem; 2017 May; 132():322-332. PubMed ID: 28407565
[TBL] [Abstract][Full Text] [Related]
34. Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of
Tassone G; Landi G; Linciano P; Francesconi V; Tonelli M; Tagliazucchi L; Costi MP; Mangani S; Pozzi C
Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209148
[No Abstract] [Full Text] [Related]
35. Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy.
Cunningham ML; Beverley SM
Mol Biochem Parasitol; 2001 Apr; 113(2):199-213. PubMed ID: 11295174
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
[TBL] [Abstract][Full Text] [Related]
37. Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
Ferrari S; Morandi F; Motiejunas D; Nerini E; Henrich S; Luciani R; Venturelli A; Lazzari S; Calò S; Gupta S; Hannaert V; Michels PA; Wade RC; Costi MP
J Med Chem; 2011 Jan; 54(1):211-21. PubMed ID: 21126022
[TBL] [Abstract][Full Text] [Related]
38. Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice.
Sienkiewicz N; Ong HB; Fairlamb AH
Mol Microbiol; 2010 Aug; 77(3):658-71. PubMed ID: 20545846
[TBL] [Abstract][Full Text] [Related]
39. 3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors.
Dube D; Periwal V; Kumar M; Sharma S; Singh TP; Kaur P
J Mol Model; 2012 May; 18(5):1701-11. PubMed ID: 21826447
[TBL] [Abstract][Full Text] [Related]
40. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
